DiscoverThe ASCO Post PodcastESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers
ESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers

ESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers

Update: 2023-07-12
Share

Description

<span data-sheets-value= "{"1":2,"2":"

This week, we’re hearing about three reports on genitourinary cancers presented at ESMO Virtual Congress 2020. We’ll hear directly from the researchers about first-line treatment for metastatic renal cell carcinoma, as well as the long-term results of a doublet therapy for men with advanced hormone-naive prostate cancer.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we’re hearing about three reports on genitourinary cancers presented at ESMO Virtual Congress 2020. We’ll hear directly from the researchers about first-line treatment for metastatic renal cell carcinoma, as well as the long-term results of a doublet therapy for men with advanced hormone-naive prostate cancer.

 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

ESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers

ESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers

The ASCO Post